+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Telemedicine Service - Market Insight, Competitive Landscape and Market Forecast, 2027

  • PDF Icon

    Report

  • 100 Pages
  • July 2022
  • Region: Global
  • DelveInsight
  • ID: 5569607
Telemedicine Service Market By Service Type (Tele Consulting And Tele Monitoring), By Application (Telepathology, Telecardiology, Teleradiology, Teledermatology, Telepsychiatry, Other Services), By End-User (Healthcare Facilities And Homecare), by geography, is projected to grow at a significant CAGR forecast till 2027 owing to the sudden outbreak of covid-19 pandemic and shifting focus for reducing the burden of healthcare cost

The global telemedicine service market was valued at USD 5,977.31 million in 2021, growing at a CAGR of 14.69% during the forecast period from 2022 to 2027, to reach USD 13,506.45 million by 2027. The increase in demand for telemedicine services is primarily attributed to the shifting focus among the population on lowering the healthcare cost, and the sudden outbreak of COVID-19 across the globe. Moreover, an upsurge in various chronic disorders across the globe, and a rise in various national government initiatives to launch telemedicine services to provide increased access among the patient population, among others are also expected to bolster the demand for these services during the forecast period (2022-2027).

Telemedicine Service Market Dynamics:


The market for telemedicine service is gaining pace at present owing to the rising burden of various chronic disorders and an increase in out-of-pocket expenditure which has considerably increased the healthcare cost across the globe. For instance, according to the World Health Organization (WHO) 2020 data, global spending on health reached USD 8.3 trillion (approximately 10% of global GDP) in the year 2018.

Moreover, as per the same source, the share of out-of-pocket expenses in total healthcare spending remained almost above 40% in low and lower-middle-income countries.

The adoption of telemedicine services such as teleconsultation is likely to lower the growing burden of shooting healthcare costs by offering cheaper services like reducing transportation costs, reducing medical costs, and others thereby propelling the global telemedicine market.

In addition, the sudden outbreak of the COVID-19 pandemic has also increased the adoption of telemedicine services by many folds across the globe. This is because, in response to curbing the transmission of COVID-19 infection, telemedicine service has emerged as an essential component of healthcare. For instance, as per the Telemedicine Society of India published in the year 2020, India has recorded a 3X increase in the number of people using online consultations, while in-person appointments have reduced by 32 percent between March to November 2020. Similar trends were expected to be observed in various other regions also which spiked the market for telemedicine services.

Furthermore, to protect patients and healthcare providers from COVID-19 community transmission, the Australian government has expanded access to telehealth in March 2020 through temporary MBS telehealth items.

Hence, with the rise in initiatives to use telemedicine by various governments along with above-mentioned factors are expected to increase the market for telemedicine services during the forecast period from 2022-2027.

However, limitations such as privacy concerns, and lack of awareness among the population living in remote areas are some of the factors expected to limit the telemedicine services market.

Telemedicine Service Market Segment Analysis:


Telemedicine Service Market By Service Type (Tele Consulting and Tele Monitoring), By Application (Telepathology, Telecardiology, Teleradiology, Teledermatology, Telepsychiatry, Other Services), By End-User (Healthcare Facilities and Homecare), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the application segment of telemedicine service market, the telecardiology application is expected to hold a significant market share in the year 2021. This is owing to the increase in various cardiovascular disorders such as arrhythmias, coronary artery disease, congenital heart diseases, and others, worldwide. For instance, as per the statistics published by the Centers for Disease Control and Prevention (CDC) in the year 2021, an estimated 12.1 million people in the US will have atrial fibrillation by 2030. Additionally, according to the Australian Government data published in 2020, approximately 2% of the general population - equivalent to more than 500,000 people were affected by atrial fibrillation in Australia in the same year.

Also, a rise in the company's business activities to become a leading telecardiology service provider is expected to increase the segmental growth during the forecast period. For instance, on June 04, 2021, WELL Health Technologies Corp., a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector has entered into a definitive share purchase agreement to acquire MyHealth Partners Inc., a provider of primary care, specialty care, telehealth services, and accredited diagnostic health services to become the leading multi-disciplinary provider of telehealth services in Canada due to the breadth and depth of primary and secondary healthcare service offerings including a substantial telecardiology and teleradiology program.

Moreover, the launch of the various mobile application for telecardiology is also anticipated to boost the segment growth. For instance, in October 2020, the government of India launched a mobile application for telecardiology at the civil hospital in Ahmedabad.

Thus, the interplay of all the above-mentioned factors is projected to augment the telecardiology segment market in the upcoming years.

North America is expected to dominate the overall Telemedicine Service Market:


Among all the regions, North America is expected to occupy a major share in the global telemedicine services market in the year 2021 and continue to do the same during the forecast period from 2022 to 2027.

This domination is due to the rise in digitalization across the healthcare sector in the region. Moreover, an increase in strategic partnership among hospitals, companies, and various associations to develop telehealth strategies to connect with patients in a remote locations during the pandemic has increased the telemedicine service market in the region and is also likely to boost the market growth of the same in the forthcoming years. For instance, in June 2020, Royal Philips, a global leader in health technology joined forces with the American Telemedicine Association (ATA) to help further the adoption of telehealth across the industry, demonstrating its commitment to connecting care across acute, post-acute, and home care settings. The continued collaboration spotlights the growing adoption and momentum in telehealth amidst COVID-19, and the need to convey the exponential shift to telehealth capabilities.

Furthermore, the government initiative to increase the adoption of telemedicine services in the region is also likely to strengthen the market. For instance, in March 2020, the Centers for Medicare & Medicaid Services (CMS) has broadened access to Medicare telehealth services so that beneficiaries can receive a wider range of services from their doctors without travelling to a healthcare facility during the COVID-19 pandemic under the 1135 waiver authority and Coronavirus Preparedness and Response Supplemental Appropriations Act.

Additionally, the presence of key telemedicine service providers such as Teladoc Health, MDLive, MeMD, among others, and their focus on advancing the telemedicine services in the region is further projected to increase the adoption of these services in the region thereby fuelling the market in the forthcoming years. For instance, on May 20, 2020, Amwell raised USD 194 million in a new round of funding which included prominent health industry leaders such as Takeda and Allianz X. the significant part of the funding will be invested by Amwell to develop new technologies and advance its telemedicine services.

Hence, all the aforementioned factors are likely to boost the regional market for telemedicine services during the forecast period.

Telemedicine Service Market Key Players:


Some of the key market players operating in the telemedicine service market include Teladoc Health, Inc., MEDICI, American Well, Doximity, Inc., Practo., DocOnline, MeMD®, iCliniq, HealthTap, Inc., WELL Health Technologies Corp., Doctor On Demand (Included Health, Inc.), Vesta Teleradiology, USARAD.COM, AGOKO NV, Nischidha Imaging Services, Array Behavioral Care., SOC Telemed, Smart Telecardiology (Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd.), First Derm, DirectDerm, and others.

Recent Developmental Activities in the Telemedicine Service Market:

  • In July 2021, Cairo-based e-health and teleconsultations platform, Estshara raised a USD 500,000 seed funding round to expand its user base by providing extra offerings and customer care activities.
  • In January 2020, Teladoc Health, Inc., the global leader in virtual care, entered into a definitive agreement to acquire InTouch Health, the leading provider of enterprise telehealth solutions for hospitals and health systems.
  • In November 2020, Morneau Shepell, a leading provider of total wellbeing, mental health, and digital mental health services, launched its first unified telemedicine solution in the United States.

Key Takeaways from the Telemedicine Service Market Report Study

  • Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Telemedicine Service market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened over the last 3 years
  • Key companies dominating the Global Telemedicine Service Market.
  • Various opportunities available for the other competitor in the Telemedicine Service Market space.
  • What are the top-performing segments in 2021? How these segments will perform in 2027.
  • Which are the top-performing regions and countries in the current market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Telemedicine Service market growth in the coming future?

Target Audience who can be benefited from the Telemedicine Service Market Report Study

  • Telemedicine Service providers
  • Research organizations and consulting companies
  • Telemedicine Service-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders in Telemedicine Service
  • Various End-users who want to know more about the Telemedicine Service Market and the latest technological developments in the Telemedicine Service market.

Frequently Asked Questions for the Telemedicine Service Market:


1. What is Telemedicine Service?
Telemedicine, also known as e-medicine is the remote delivery of the healthcare services such as consultations, examining, and monitoring over the telecommunication infrastructure. This service allows healthcare professionals to evaluate, diagnose, and treat patients without the requirement of an in-person visit.

2. What is the market for Global Telemedicine services?
The global telemedicine service market was valued at USD 5,977.31 million in 2021, growing at a CAGR of 14.69% during the forecast period from 2022 to 2027, to reach USD 13,506.45 million by 2027.

3. What are the drivers for the Global Telemedicine Service?
The major factor driving the demand for telemedicine service is the shifting focus among the population on lowering the healthcare cost, and the sudden outbreak of COVID-19 across the globe. Moreover, an upsurge in various chronic disorders across the globe, and a rise in government initiatives to launch telemedicine services to provide increased access among the patient population during the forecast period.

4. What are the key players operating in Global Telemedicine Service?
Some of the key market players operating in the telemedicine service market include Teladoc Health, Inc., MEDICI, American Well, Doximity, Inc., Practo., DocOnline, MeMD®, iCliniq, HealthTap, Inc., WELL Health Technologies Corp., Doctor On Demand (Included Health, Inc.), Vesta Teleradiology, USARAD.COM, AGOKO NV, Nischidha Imaging Services, Array Behavioral Care., SOC Telemed, Smart Telecardiology (Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd.), First Derm, DirectDerm, and others.

5. Which region has the highest share in the telemedicine service market?
Among all the regions, North America is expected to occupy a major share in the global telemedicine services market in the year 2021 and continue to do the same during the forecast period from 2022 to 2027. This domination is due to the rise in digitalization across the healthcare sector in the region. Moreover, an increase in strategic partnership among hospitals, companies, and various associations to develop telehealth strategies to connect with patients in remote locations during the pandemic is also likely to increase the regional telemedicine service market.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.

Table of Contents

1. Telemedicine Service Market Report Introduction
2. Telemedicine Service Market Executive summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. Regulatory and Patent Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. Telemedicine Service Market Key factors analysis
4.1. Telemedicine Service Market Drivers
4.1.1. The rise in shifting focus among the population for lowering the healthcare cost
4.1.2. The sudden outbreak of the COVID-19 pandemic
4.1.3. Rise in government initiatives to launch telemedicine services to provide increased access among the patient population
4.2. Telemedicine Service Market Restraints and Challenges
4.2.1. Limitations such as privacy concerns
4.2.2. Lack of awareness among the population living in remote areas
4.3. Telemedicine Service Market Opportunities
4.3.1. The market has a high potential for growth with a significant likelihood of start-ups and large firms entering the telemedicine market
4.3.2. Opportunities in healthcare technology spurred by new digital technologies (5G, big data and artificial intelligence, cybersecurity)
5. Telemedicine Service Porter's Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 Impact Analysis on Telemedicine Service Market
7. Telemedicine Service Market layout
7.1. By Service Type
7.1.1. Tele Consulting
7.1.2. Tele Monitoring
7.2. By Application
7.2.1. Telepathology
7.2.2. Telecardiology
7.2.3. Teleradiology
7.2.4. Teledermatology
7.2.5. Telepsychiatry
7.2.6. Other Service
7.3. By End-User
7.3.1. Healthcare Facilities
7.3.2. Homecare
7.4. By Geography
7.4.1. North America
7.4.1.1. United States
7.4.1.2. Canada
7.4.1.3. Mexico
7.4.2. Europe
7.4.2.1. France
7.4.2.2. Germany
7.4.2.3. United Kingdom
7.4.2.4. Italy
7.4.2.5. Spain
7.4.2.6. Russia
7.4.2.7. Rest of Europe
7.4.3. Asia-Pacific
7.4.3.1. China
7.4.3.2. Japan
7.4.3.3. India
7.4.3.4. Australia
7.4.3.5. South Korea
7.4.3.6. Rest of Asia Pacific
7.4.4. Rest of the World (RoW)
7.4.4.1. Middle East
7.4.4.2. Africa
7.4.4.3. South America
8. Telemedicine Service Company and Product Profiles
8.1. Teladoc Health, Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Financial Overview
8.1.4. Product Listing
8.1.5. Entropy
8.2. MEDICI
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Financial Overview
8.2.4. Product Listing
8.2.5. Entropy
8.3. American Well
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Financial Overview
8.3.4. Product Listing
8.3.5. Entropy
8.4. Doximity, Inc.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Financial Overview
8.4.4. Product Listing
8.4.5. Entropy
8.5. Practo.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Financial Overview
8.5.4. Product Listing
8.5.5. Entropy
8.6. DocOnline
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Financial Overview
8.6.4. Product Listing
8.6.5. Entropy
8.7. MeMD®
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Financial Overview
8.7.4. Product Listing
8.7.5. Entropy
8.8. iCliniq
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Financial Overview
8.8.4. Product Listing
8.8.5. Entropy
8.9. HealthTap, Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Financial Overview
8.9.4. Product Listing
8.9.5. Entropy
8.10. WELL Health Technologies Corp.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Financial Overview
8.10.4. Product Listing
8.10.5. Entropy
8.11. Doctor On Demand (Included Health, Inc.)
8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Financial Overview
8.11.4. Product Listing
8.11.5. Entropy
8.12. Vesta Teleradiology
8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Financial Overview
8.12.4. Product Listing
8.12.5. Entropy
8.13. USARAD.COM
8.13.1. Company Overview
8.13.2. Company Snapshot
8.13.3. Financial Overview
8.13.4. Product Listing
8.13.5. Entropy
8.14. AGOKO NV
8.14.1. Company Overview
8.14.2. Company Snapshot
8.14.3. Financial Overview
8.14.4. Product Listing
8.14.5. Entropy
8.15. Nischidha Imaging Services
8.15.1. Company Overview
8.15.2. Company Snapshot
8.15.3. Financial Overview
8.15.4. Product Listing
8.15.5. Entropy
8.16. Array Behavioral Care.
8.16.1. Company Overview
8.16.2. Company Snapshot
8.16.3. Financial Overview
8.16.4. Product Listing
8.16.5. Entropy
8.17. SOC Telemed
8.17.1. Company Overview
8.17.2. Company Snapshot
8.17.3. Financial Overview
8.17.4. Product Listing
8.17.5. Entropy
8.18. Smart Telecardiology (Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd.)
8.18.1. Company Overview
8.18.2. Company Snapshot
8.18.3. Financial Overview
8.18.4. Product Listing
8.18.5. Entropy
8.19. First Derm
8.19.1. Company Overview
8.19.2. Company Snapshot
8.19.3. Financial Overview
8.19.4. Product Listing
8.19.5. Entropy
8.20. DirectDerm
8.20.1. Company Overview
8.20.2. Company Snapshot
8.20.3. Financial Overview
8.20.4. Product Listing
8.20.5. Entropy
9. KOL Views10. Project Approach11. About the Publisher12. Disclaimer & Contact the Publisher
List of Tables
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis on Telemedicine Service Market
Table 3: Telemedicine Service Market Analysis in Global (2019-2027)
Table 4: Telemedicine Service Market Analysis in Global by Service Type (2019-2027)
Table 5: Telemedicine Service Market Analysis in Global by Application (2019-2027)
Table 6: Telemedicine Service Market Analysis in Global by End User (2019-2027)
Table 7: Telemedicine Service Market Analysis in Global by Geography (2019-2027)
Table 8: Telemedicine Service Market Analysis in North America (2019-2027)
Table 9: Telemedicine Service Market Analysis in the US (2019-2027)
Table 10: Telemedicine Service Market Analysis in Canada (2019-2027)
Table 11: Telemedicine Service Market Analysis in Mexico (2019-2027)
Table 12: Telemedicine Service Market Analysis in Europe (2019-2027)
Table 13: Telemedicine Service Market Analysis in France (2019-2027)
Table 14: Telemedicine Service Market Analysis in Germany (2019-2027)
Table 15: Telemedicine Service Market Analysis in the UK (2019-2027)
Table 16: Telemedicine Service Market Analysis in Italy (2019-2027)
Table 17: Telemedicine Service Market Analysis in Spain (2019-2027)
Table 18: Telemedicine Service Market Analysis in Russia (2019-2027)
Table 19: Telemedicine Service Market Analysis in Rest of Europe (2019-2027)
Table 20: Telemedicine Service Market Analysis in Asia-Pacific (2019-2027)
Table 21: Telemedicine Service Market Analysis in China (2019-2027)
Table 22: Telemedicine Service Market Analysis in Japan (2019-2027)
Table 23: Telemedicine Service Market Analysis in India (2019-2027)
Table 24: Telemedicine Service Market Analysis in Australia (2019-2027)
Table 25: Telemedicine Service Market Analysis in South Korea (2019-2027)
Table 26: Telemedicine Service Market Analysis in Rest of Asia-Pacific (2019-2027)
Table 27: Telemedicine Service Market Analysis in Rest of World (2019-2027)
Table 28: Telemedicine Service Market Analysis in the Middle East (2019-2027)
Table 29: Telemedicine Service Market Analysis in Africa (2019-2027)
Table 30: Telemedicine Service Market Analysis in South America (2019-2027)
List of Figures
Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis on Telemedicine Service Market
Figure 3: Telemedicine Service Market Analysis in Global (2019-2027)
Figure 4: Telemedicine Service Market Analysis in Global by Service Type (2019-2027)
Figure 5: Telemedicine Service Market Analysis in Global by Application (2019-2027)
Figure 6: Telemedicine Service Market Analysis in Global by End User (2019-2027)
Figure 7: Telemedicine Service Market Analysis in Global by Geography (2019-2027)
Figure 8: Telemedicine Service Market Analysis in North America (2019-2027)
Figure 9: Telemedicine Service Market Analysis in the US (2019-2027)
Figure 10: Telemedicine Service Market Analysis in Canada (2019-2027)
Figure 11: Telemedicine Service Market Analysis in Mexico (2019-2027)
Figure 12: Telemedicine Service Market Analysis in Europe (2019-2027)
Figure 13: Telemedicine Service Market Analysis in France (2019-2027)
Figure 14: Telemedicine Service Market Analysis in Germany (2019-2027)
Figure 15: Telemedicine Service Market Analysis in the UK (2019-2027)
Figure 16: Telemedicine Service Market Analysis in Italy (2019-2027)
Figure 17: Telemedicine Service Market Analysis in Spain (2019-2027)
Figure 18: Telemedicine Service Market Analysis in Russia (2019-2027)
Figure 19: Telemedicine Service Market Analysis in Rest of Europe (2019-2027)
Figure 20: Telemedicine Service Market Analysis in Asia-Pacific (2019-2027)
Figure 21: Telemedicine Service Market Analysis in China (2019-2027)
Figure 22: Telemedicine Service Market Analysis in Japan (2019-2027)
Figure 23: Telemedicine Service Market Analysis in India (2019-2027)
Figure 24: Telemedicine Service Market Analysis in Australia (2019-2027)
Figure 25: Telemedicine Service Market Analysis in South Korea (2019-2027)
Figure 26: Telemedicine Service Market Analysis in Rest of Asia-Pacific (2019-2027)
Figure 27: Telemedicine Service Market Analysis in Rest of World (2019-2027)
Figure 28: Telemedicine Service Market Analysis in the Middle East (2019-2027)
Figure 29: Telemedicine Service Market Analysis in Africa (2019-2027)
Figure 30: Telemedicine Service Market Analysis in South America (2019-2027)
Figure 31: Market Drivers
Figure 32: Market Barriers
Figure 33: Market Opportunities
Figure 34: PORTER's Five Force Analysis

Companies Mentioned

A selection of companies mentioned in this report includes:

  • GlaxoSmithKline
  • Eli Lilly & Company
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Amgen Inc
  • Sanofi
  • Merck & Co., Inc
  • Novartis AG
  • Pfizer Inc
  • AstraZeneca
  • Bristol Myers Squibb
  • Gilead Sciences, Inc.
  • Janssen Global Services, LLC,
  • Elekta AB
  • Varian Medical Systems, Inc
  • Accuray Incorporated
  • Pyrexar Medical
  • Eckert & Ziegler
  • IBA
  • Panacea Medical Technologies Pvt. Ltd